

2026
* Likely, but not yet confirmed by Neuralink, the patient, or the trial site.
Terence (Terry) Mandable is Neuralink patient 25 and the third participant in the VOICE trial, which tests whether the implant can restore speech. He was diagnosed with bulbar-onset ALS in 2024, a form of the disease that takes speech first while the arms and legs keep working. He received his implant at UT Southwestern in Dallas, and it is in the speech motor region with 3,000 channels. In September 2026 Neuralink shared video of him telling his wife "I love you" in a voice decoded from his brain and rebuilt from recordings made before ALS, and CBS Evening News covered his story.
Patient details come from the patient's own public posts, Neuralink, trial sites, and news reports. This page is general information about an investigational device and is not medical advice.
More publicly identified Neuralink patients